Analyte measuring device

Inactive Publication Date: 2005-02-10
DEXCOM
View PDF98 Cites 1001 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0110] The devices of the preferred embodiments allow continuous information regarding, for example, glucose levels. Such continuous inf

Problems solved by technology

Despite the increasing number of individuals diagnosed with diabetes and recent advances in the field of implantable glucose monitoring devices, currently used devices are unable to provide data safely and reliably for long periods of time (for example, months or years).
With reference to conventional devices that can be implanted in tissue, a disadvantage of these devices is that they tend to lose their function after the first few days to weeks following implantation.
While not wishing to be bound by any particular theory, it is believed that this loss of function is due to the lack of direct contact with circulating blood to deliver sample to the tip of the probe of the implanted device.
Because of these limitations, it has previously been difficult to obtain continuous and accurate glucose level measurements.
A disadvantage of cell-impermeable membranes is that they often stimulate a local inflammatory response, called the foreign body response (FBR) that has long been recognized as limiting the function of implanted devices that require solute transport.
Previous efforts to overcome this problem have been aimed at increasing local vascularization at the device-tissue interface, but have achieved only limited success.
This has led to widely supported speculation that poor transport of molecules across the device-tissue interface 26 is due to a lack of vascularization near the interface.
Previous efforts to overcome t

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Analyte measuring device
  • Analyte measuring device
  • Analyte measuring device

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0319] The polyurethanes are preferably prepared as block copolymers by solution polymerization techniques as generally described in Lyman, J. Polymer Sci. 45:49 (1960). Specifically, a two-step solution polymerization technique is used in which the poly(oxyethylene) glycol is first “capped” by reaction with a diisocyanate to form a macrodiisocyanate. The macrodiisocyanate is then coupled with a diol (or diamine) and the diisocyanate to form a block copolyetherurethane (or a block copolyurethaneurea). The resulting block copolymers are tough and elastic and can be solution-cast in N,N-dimethylformamide to yield clear films that demonstrate good wet strength when swollen in water.

[0320] In particular, a mixture of 8.4 g (0.006 mol), poly(oxyethylene) glycol (CARBOWAX® 1540, Union Carbide), and 3.0 g (0.012 mol) 4,4′-diphenylmethane diisocyanate in 20 mL dimethyl sulfoxide / 4-methyl-2-pentanone (50 / 50) is placed in a three-necked flask equipped with a stirrer and condenser and protect...

example 2

[0322] As previously described, the electrolyte layer, the membrane layer closest to the electrode, can be coated as a water-swellable film. This example illustrates a coating comprising a polyurethane having anionic carboxylate functional groups and hydrophilic polyether groups and polyvinylpyrrolidone (PVP) that can be cross-linked by carbodiimide.

[0323] A coating preparation is prepared comprising a premix of a colloidal aqueous dispersion of particles of a urethane polymer having a polycarbonate-polyurethane (PC-PU) backbone containing carboxylate groups and the water-soluble hydrophilic polymer, PVP, which is crosslinked by the addition of the cross-linking agent just before production of the coated membrane. Example coating formulations are illustrated in Table 1.

TABLE 1ABCDryDryDryWeightWeightWeight%%%WeightSolidsWeightSolidsWeightSolidsPremixPVP148664816020PC-PV2260912488720070Cross-LinkingAgentCarbodiimide3631052010Totals314100322100380100

1Aqueous solution containing 12....

example 3

[0326] The following procedure was used to determine the amount of enzyme to be included in the enzyme layer. It is to be understood that the preferred embodiments are not limited to the use of this or a similar procedure, but rather contemplates the use of other techniques known in the art.

[0327] A starting glucose oxidase concentration of 2×10−4 M was calculated from the enzyme weight and the final volume of the enzyme layer. Thereafter, a series of eight additional membrane formulations was prepared by decrementing enzyme concentration in 50% steps (referred to as a change of one “half loading”) down to 7.8−7 M. Sensor responses were then collected for this range of enzyme loadings and compared to computer-simulated sensor outputs. The simulation parameter set used included previously determined membrane permeabilities and the literature mechanisms and kinetics for glucose oxidase. See, e.g., Rhodes el al., Anal. Chem., 66:1520-1529 (1994).

[0328] There was a good match of real-...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Structureaaaaaaaaaa
Electrical resistanceaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to view more

Abstract

An implantable analyte-measuring device including a membrane adapted to promote vascularization and/or interfere with barrier cell layer formation. The membrane includes any combination of materials, architecture, and bioactive agents that facilitate analyte transport to provide long-term in vivo performance of the implantable analyte-measuring device.

Description

RELATED APPLICATIONS [0001] This application is a continuation-in-part of application Ser. No. 10 / 647,065, filed Aug. 22, 2003, which claims the benefit of priority under 35 U.S.C. § 119(e) to Provisional Application No. 60 / 472,673, filed May 21, 2003, and is a continuation-in-part of application Ser. No. 09 / 447,227, filed Nov. 22, 1999, which is a division of application Ser. No. 08 / 811,473, filed Mar. 4, 1997, now U.S. Pat. No. 6,001,067. This application claims the benefit of priority under 35 U.S.C. § 119(e) to Provisional Application No. 60 / 544722, filed Feb. 12, 2004. All above-referenced prior applications are incorporated by reference herein in their entirety.FIELD OF THE INVENTION [0002] The present invention relates generally to biointerface membranes that can be utilized with implantable devices, such as devices for the detection of analyte concentrations in a biological sample. The present invention further relates to methods for determining analyte levels using implanta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61B5/00A61K9/22A61L31/10A61L31/14A61L31/16C12Q1/00
CPCA61B5/14532A61B5/14865A61B5/1495A61L31/10C12Q1/006A61L31/146A61L31/16A61L2300/00A61L31/14B33Y80/00
Inventor SHULTS, MARK C.BRAUKER, JAMES H.CARR-BRENDEL, VICTORIATAPSAK, MARKMARKOVIC, DUBRAVKAUPDIKE, STUART J.RHODES, RATHBUN K.
Owner DEXCOM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products